Cardiotoxic effects of fenfluramine hydrochloride on isolated cardiac preparations and ventricular myocytes of guinea-pigs

British Journal of Pharmacology

Volumn 129, Issue 5, 2000, Pages 843-852

  Rajamani, Sridharan ^a   Studenik, Christian ^a   Lemmens Gruber, Rosa ^a   Heistracher, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiomyocytes; Cardiotoxicity; Fenfluramine; Patch clamp technique; Sodium current

Indexed keywords

FENFLURAMINE; SODIUM CHANNEL;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; FEMALE; GUINEA PIG; HEART CONTRACTION; HEART LEFT ATRIUM; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; HYPERPOLARIZATION; INOTROPISM; INTRACELLULAR RECORDING; MALE; MICROELECTRODE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PURKINJE FIBER; SODIUM CURRENT;

ACTION POTENTIALS; ANIMALS; APPETITE DEPRESSANTS; CARDIOTONIC AGENTS; FEMALE; FENFLURAMINE; GUINEA PIGS; HEART; HEART VENTRICLES; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PAPILLARY MUSCLES; PIPERAZINES; PURKINJE FIBERS; SODIUM CHANNELS;

EID: 0034057082     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703118     Document Type: Article

References (41)

1. Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., Simonneau, G. & Begaurd, B. (1996). Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N. Eng. J. Med., 335, 609-616.
2. Cachelin, A.B., De Peyer, J.E., Kokubun, S. & Reuter, H. (1983). Sodium channels in cultured cardiac cells. J. Physiol., 415, 503-531.
3. Cannistra, L.B., Davis, S.M , Bauman, A.G. (1997). Valvular heart disease associated with dexfenfluramine. N. Engl. J. Med., 337, 636.
4. + channel of rabbit cardiac Purkinje fibres. Circ. Res., 63, 50-60.
5. Carmeliet, E. & Mubagwa, K. (1998). Antiarrhythmic drugs and cardiac ion channels: mechanisms of action. Prog. Biophys. Mol. Biol., 70, 1-72.
6. Cohen, C.J., Bean, B.P. & Tsien, R.W. (1984). Maximal upstroke velocity as an index of available sodium conductance: comparison of maximal upstroke velocity and voltage-clamp measurements of sodium current in rabbit Purkinje fibres. Circ. Res., 54, 636 -651.
7. Connolly, H.M., Crary, J.L., McGoon, M.D., Hensrud, D.D., Edwards, B.S., Edwards, W.D. & Schaff, H.V. (1997). Valvular heart disease associated with fenfluramine-phentermine. New. Eng. J. Med., 337, 581-588.
8. Dollery, C. (1991). Fenfluramine (hydrochloride). In: Therapeutic drugs. Vol. 1. Churchill Livingston: London, pp. F16-F19.
9. Costa, E., Groppetti, A., Revuelta, A. (1971). Action of fenfluramine on monoamine stores of rat tissues. Br. J. Pharmacol., 41, 57-64.
10. Fernandez, J.M., Fox, A.P. & Krasne, S. (1984). Membrane patches and whole-cell membranes: a comparison of electrical properties in rat clonal pituitary (GH3) cells. J. Physiol., 356, 565-585.
11. Fitzgerald, J.L. & Reid, J.J. (1994). Sympathomimetic actions of methlenedioxy-methamphetamine in rat and rabbit isolated cardiovascular tissues. J. Pharm. Pharmacol., 46, 826-832.
12. + channels by a quaternary ammonium ion: catalysis by a transition-intermediate slate? J. Physiol., 471, 319-341.
13. Graham, D.J. & Green, L. (1997). Further cases of valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med., 337, 635.
14. Grant, A.O , Starmer, C.F. & Strauss, H.C. (1984). Antiarrhythmic drug action: blockade of the inward sodium current. Circ. Res., 55, 427-439.
15. Gruber, R & Carmeliet, E. (1989). The activation gate of sodium channel controls blockade and deblockade by disopyramide in rabbit Purkinje fibres. Br. J. Pharmacol., 97, 41-50.
16. + current of guinea-pig ventricular myocytes. J. Physiol., 435, 65-81.
17. Hamill, O.P., Marty, A., Neher, E., Sakmann, B. & Sigworth, F.J. (1981). Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch., 391, 85-100.
18. Heistracher, P. (1971). Mechanism of action of antifibrillatory drugs. Naunyn Schmiedeberg's Arch. Pharmacol., 269, 199-212.
19. Herve, P., Launay, J.M. & Scrobohaci, M.L. (1995). Increased plasma scrotonin in primary pulmonary hypertension. Am. J. Med., 99, 249-254.
20. Hille, B. (1977). Local anaesthetic: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol., 69, 497-515.
21. Hondeghem, L.M. & Katzung, B.C. (1984). Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Ann. Rev. Pharmacol. Toxicol., 24, 387-423.
22. Hunsinger, R.N. & Wright, D. (1990). A characterization of the acute cardiopulmonary toxicity of fenfluramine in the rat. Pharmacol. Res., 22, 371-378.
23. Innes, J.A., Watson, M.L., Ford, M.J., Munro, J.F., Stoddant, M.C., Campbell, D.B. (1977). Plasma fenfluramine levels, weight loss and side effects. Br. Med. J., 2, 1322-1325.
24. Jick, H., Vasilakis, C., Weinrauch, L.A., Meier, C.R., Jick, S.S. & Derby, L.E. (1998). A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. New. Eng. J. Med., 339, 719-724.
25. Khan, M.A., Herzog, C.A., Peter, J.V., Hartley, G.G., MaDlon-Kay, R., Dick, C.D., Asinger, R.W. & Vessey, J.T. (1998). The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. New. Engl. J. Med., 339, 713-718.
26. + channels by DPI 201-106. Am. J. Physiol., 89, H163-H172.
27. Makielski, J.C., Sheets, M.F., Hanck, D.A., January, C.T. & Fozzard, H.A. (1987). Sodium current in voltage clamped internally perfused canine cardiac Purkinje cells. Biophys. J., 52, 1-11.
28. Michelakis, E.D., Archer, S.L., Huang, J.M.C., Neeson, D.P. & Weir, E.K. (1995). Anorexic agents inhibit potassium current in pulmonary artery smooth muscle cells. Am. J. Respir. Crit. Care. Med., 151, A725.
29. Mitra, R. & Morad, M. (1985). A uniform enzymatic method for dissociation of myocytes from heart and stomachs of vertebrates. Am. J. Physiol., 249, H1056-H1060.
30. Mullen, A., Wilson, C.W.M. & Wilson, B.P.M. (1977). Dreaming, fenfluramine, and vitamin C. Br. Med J., 1, 70-72.
31. Reiter, M. (1967). Evaluation of inotropically active drugs on isolated papillary muscle. Arzneimittelforschung, 17, 1249-1253.
32. Rounds, S. & Cutaia, M.V. (1998). Pulmonary hypertension: Pathophysiology and clinical disorders. In: Textbook of Pulmonary diseases. ed. Baum, G.L., Crapo, B.R. & Karlinsky, J.B. Lippincott-Raven Publishers: Philadelphia, pp. 1273-1295.
33. Rowland, N.E. & Carlton, J. (1986). Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol., 21, 13-62.
34. US Department of Health and Human Services. (1997). Morbidity Mortality Weekly Report., 46, 1061-1066.
35. Veltri, J.C. & Temple, A.R. (1975). Fenfluramine poisoning. J. Pediatr., 87, 119-121.
36. Voelker, R. (1994). Obesity drug renews toxicity debate. JAMA., 272, 1087-1088.
37. + channel subtypes. Biophys. J., 70, 1700-1708.
38. Weir, E.K., Reeve, H.L., Huang, J.M.C., Michelakis, E., Nelson, D.P., Hampl, V. & Archer, S.L. (1996). Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circ. Res., 94, 2216-2220.
39. Weissman, N.J., Tighe, Jr, J.F., Gottdiener, J.S. & Gwynne, J.T. (1998). An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group. New. Eng. J. Med., 339, 725-732.
40. Yeh, J.Z. & Tanguy, J. (1985). Na channel activation gate modulates slow recovery from use-dependent block by local anesthetics in squid giant axons. Biophys. J., 47, 685-694.
41. Zamponi, G.W. & French, R.J. (1994). Transcainide causes two modes of open-channel block with different voltage sensitivities in batrachotoxin-activated sodium channels. Biophys. J., 67, 1028-1039.